Amgen's stock paces the Dow's decliners after analyst downgrade in wake of disappointing trial resultsMarket Watch • 10/09/20
Amgen, Cytokinetics Partnership Disappoints With Data On Heart TreatmentInvestors Business Daily • 10/08/20
Amgen Announces Positive Topline Phase 2 Results For Investigational KRAS G12C Inhibitor Sotorasib In Advanced Non-Small Cell Lung CancerPRNewsWire • 10/05/20
Amgen Announces Collaboration With Two NHS Organisations to Help Improve Cholesterol Management for People at High Risk of a Heart Attack or StrokeBusiness Wire • 10/04/20
Amgen Announces Five-Year Data That Reinforce The Safety And Efficacy Profile Of Aimovig® (erenumab-aooe) In Adult Patients With Episodic MigrainePRNewsWire • 10/03/20
Congressional Committee Accuses Amgen and Peers of Hiking Drug Prices to Meet "Aggressive" Revenue TargetsThe Motley Fool • 10/02/20
Gilead, Regeneron, Amgen: Covid Treatment Stocks Still Worth Looking At As Vaccine Nears?Forbes • 10/02/20
Clinical Data From Full Phase 1 Cohort Of Investigational Sotorasib Published In New England Journal Of MedicinePRNewsWire • 09/20/20
Lilly and Amgen Announce Manufacturing Collaboration for COVID-19 Antibody TherapiesPRNewsWire • 09/17/20